ABUS — Arbutus Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Arbutus Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	155	147	126	123	91.5
Net Total Accounts Receivable
Net Total Receivables	0.899	1.35	1.78	2.41	1.45
Prepaid Expenses
Total Current Assets	161	151	132	127	94.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.07	6.81	6.09	4.36	0.032
Long Term Investments
Other Long Term Assets
Total Assets	204	195	144	132	94.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.2	32.9	22.5	15.6	6.01
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	35	58.6	38.4	34.3	18
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	169	137	106	97.4	76.6
Total Liabilities & Shareholders' Equity	204	195	144	132	94.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding